Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3a,Condition 3b 2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",glomerular filtration trait,,RS:0000742,WKY,male,0 days,11,,CMO:0002783,glomerular filtration rate to body weight ratio,,,,0.517,ml/min/100g,0.011,0.0365,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,unx,168,days,unilateral nephrectomy (for 28 days) then vehicle control condition,99980,unilateral nephrectomy (for 28 days),vehicle control condition,, 2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",glomerular filtration trait,,RS:0000742,WKY,male,0 days,17,,CMO:0002783,glomerular filtration rate to body weight ratio,,,,0.496,ml/min/100g,0.029,0.1196,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,unx,168,days,unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition,99981,unilateral nephrectomy (for 28 days),streptozotocin (35 mg/kg) ,vehicle control condition, 2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",glomerular filtration trait,,RS:0000742,WKY,male,0 days,17,,CMO:0002783,glomerular filtration rate to body weight ratio,,,,0.69,ml/min/100g,0.031,0.1278,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,unx,168,days,unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 154 days),99982,unilateral nephrectomy (for 28 days),streptozotocin (35 mg/kg) ,bosentan (100 mg/kg/d) (for 154 days), 2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",glomerular filtration trait,,RS:0000742,WKY,male,0 days,16,,CMO:0002783,glomerular filtration rate to body weight ratio,,,,0.664,ml/min/100g,0.022,0.088,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,unx,168,days,unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days),99983,unilateral nephrectomy (for 28 days),streptozotocin (35 mg/kg) ,enalapril (10 mg/kg/d) (for 154 days), 2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",glomerular filtration trait,,RS:0000742,WKY,male,0 days,16,,CMO:0002783,glomerular filtration rate to body weight ratio,,,,0.673,ml/min/100g,0.021,0.084,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,unx,168,days,unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) and bosentan (100 mg/kg/d) (for 154 days),99984,unilateral nephrectomy (for 28 days),streptozotocin (35 mg/kg) ,enalapril (10 mg/kg/d) (for 154 days),bosentan (100 mg/kg/d) (for 154 days) 2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",glomerular filtration trait,,RS:0000742,WKY,male,0 days,7,,CMO:0002783,glomerular filtration rate to body weight ratio,,,,0.494,ml/min/100g,0.03,0.0794,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days) then vehicle control condition,99945,unilateral nephrectomy (for 28 days),vehicle control condition,, 2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",glomerular filtration trait,,RS:0000742,WKY,male,0 days,8,,CMO:0002783,glomerular filtration rate to body weight ratio,,,,0.792,ml/min/100g,0.03,0.0849,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition,99946,unilateral nephrectomy (for 28 days),streptozotocin (35 mg/kg) ,vehicle control condition, 2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",glomerular filtration trait,,RS:0000742,WKY,male,0 days,8,,CMO:0002783,glomerular filtration rate to body weight ratio,,,,0.516,ml/min/100g,0.025,0.0707,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 14 days),99947,unilateral nephrectomy (for 28 days),streptozotocin (35 mg/kg) ,bosentan (100 mg/kg/d) (for 14 days), 2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",glomerular filtration trait,,RS:0000742,WKY,male,0 days,8,,CMO:0002783,glomerular filtration rate to body weight ratio,,,,0.536,ml/min/100g,0.017,0.0481,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days),99948,unilateral nephrectomy (for 28 days),streptozotocin (35 mg/kg) ,enalapril (10 mg/kg/d) (for 14 days), 2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",glomerular filtration trait,,RS:0000742,WKY,male,0 days,6,,CMO:0002783,glomerular filtration rate to body weight ratio,,,,0.504,ml/min/100g,0.023,0.0563,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) and bosentan (100 mg/kg/d) (for 14 days),99949,unilateral nephrectomy (for 28 days),streptozotocin (35 mg/kg) ,enalapril (10 mg/kg/d) (for 14 days),bosentan (100 mg/kg/d) (for 14 days)